Lv4
550 积分 2025-06-08 加入
Outcomes of Risankizumab in Patients with Crohn’s Disease and Prior Ustekinumab Exposure in a Multicenter Academic Institution
11天前
已完结
A Case Series of TNF Inhibitor-Induced Psoriasis Successfully Treated With Upadacitinib
1个月前
已完结
Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease
1个月前
已完结
Letter: addition of methotrexate neither restores clinical response nor improves the pharmacokinetic profile of vedolizumab‐treated patients
1个月前
已完结
Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial
1个月前
已完结
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials
1个月前
已完结
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
1个月前
已完结
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)
1个月前
已完结
Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States
2个月前
已完结
Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
2个月前
已完结
皖公网安备34019202002308
